CATRO-FRAG (HGH Frag 176-191) 2 mg x 10 Vials – CAT Pharmaceuticals

Description

CAT Pharmaceuticals CATRO-FRAG (HGH Frag 176-191) is a premium peptide research formulation containing HGH Fragment 176-191, a synthetic peptide derived from the C-terminal region of Human Growth Hormone (HGH). Developed exclusively for laboratory research, HGH Frag 176-191 is extensively investigated for its role in lipid metabolism, adipocyte biology, peptide pharmacology, and metabolic signaling. Its unique structure has made it an important investigational peptide in studies involving energy homeostasis and molecular endocrinology.

By interacting with biological pathways involved in fat metabolism and cellular signaling, HGH Frag 176-191 enables researchers to investigate lipolytic signaling, adipose tissue physiology, metabolic regulation, peptide-receptor interactions, and intracellular communication. Its specialized pharmacological profile has established it as a valuable research peptide for metabolic and endocrine investigations.

Each package contains 10 sterile vials, with 2 mg of HGH Frag 176-191 per vial, manufactured by CAT Pharmaceuticals under stringent pharmaceutical-quality standards. Every batch undergoes comprehensive quality testing to ensure exceptional purity, peptide integrity, and dependable laboratory performance.

Key Features

• Premium HGH Fragment 176-191 peptide research formulation
• 2 mg per vial
• 10 sterile vials per package
• Synthetic peptide derived from Human Growth Hormone (HGH)
• High-purity laboratory-grade peptide
• Extensively researched in lipid metabolism and metabolic physiology
• Suitable for investigations involving adipocyte biology, peptide pharmacology, metabolic regulation, cellular signaling, energy homeostasis, and molecular endocrinology
• Manufactured under rigorous pharmaceutical-quality standards
• Intended exclusively for laboratory and scientific research applications

How It Works

HGH Fragment 176-191 is a synthetic peptide corresponding to amino acids 176-191 of the human growth hormone molecule. Researchers utilize this peptide to investigate molecular pathways associated with lipid metabolism, adipose tissue biology, peptide-mediated signaling, and metabolic regulation.

In laboratory studies, HGH Frag 176-191 is extensively used to examine peptide-receptor interactions, intracellular signaling pathways, adipocyte physiology, energy metabolism, endocrine communication, and molecular pharmacology. Its unique peptide structure continues to make it an important investigational compound for advanced metabolic and endocrine research.

This formulation is intended exclusively for laboratory and scientific research and is not intended for human consumption.

Contents

Active Ingredient (Per Vial):

• HGH Fragment 176-191 – 2 mg

Packaging: 10 Sterile Vials